HIF1A and neoplasm: Finally, therapeutic targeting of hypoxia through treatment with terazapamine and FM19G11 (a small molecule inhibitor of HIF-1α and HIF-2α) resulted in a marked reduction of tumor growth and a corresponding decrease in TSD+ CSCs and CTCs and the presence of R-CSCs within the BM (Figures 10A–C).